CROMA PHARMA en RUCK TMED maken nieuwe systemen voor oogchirurgie
Array
Croma Pharma GmbH, een wereldwijde gespecialiseerde onderneming in farmaceutische en chirurgische producten, en het chirurgische bedrijf Ruck Tmed (fusie van Fritz Ruck GmbH en T.MED GmbH) maken vandaag bekend een internationaal strategisch partnerschap te zijn aangegaan voor de gezamenlijke promotie van een nieuwe generatie systemen voor oogchirurgie die voordelen bieden ten opzichte van de thans beschikbare apparaten. De samenwerking zal zich richten op de tot nu toe door Ruck Tmed ontwikkelde en nu ook door Croma Pharma GmbH ondersteunde faco-emulsificatie en vitrectomie-operatiesystemen.
Engelstalig bericht:
CROMA PHARMA GmbH and RUCK TMED Announce a Global Partnership to Develop and Market a New Generation of Ophthalmic Surgical Systems
Today, Croma Pharma GmbH, a private global specialty pharmaceutical and surgical company and Ruck Tmed (merger of Fritz Ruck GmbH and T.MED GmbH), a private surgical company announced a global strategic partnership to co-promote a new generation ofophthalmology surgery systems having advantages over currently available devices. The partnership will focus on phacoemulisification and vitrectomy surgical systems, so far developed by Ruck Tmed and now supported by Croma Pharma GmbH.
The global distribution and the promotion of the new systems will be shared by Croma and Ruck Tmed. While the products in Germany, Switzerland and the Benelux will exclusively be distributed and promoted by Ruck Tmed, Croma Pharma will supply all other markets worldwide.
“Setting a new standard for ocular surgical systems is the goal of this partnership†stated Andreas Prinz, Managing Director of Croma GmbH “the combination of Ruck’s 30+ years of cutting edge design and development with Croma’s extensive distribution network will generate real synergistic advances for ophthalmic surgeons worldwide.â€
“As an innovative company it is a pleasure for us to work together with Croma Pharma when it comes to the global marketing and distribution of our newest products†says Michael Ruck, Managing Director of Ruck Tmed “Croma has 35 years of experience and by utilizing their dedicated sales forces and their extensive distribution network in more than 62 countries this partnership will truly have global reach.â€
****************
CROMA Pharma is a private global specialty pharmaceutical and surgical company dedicated to improving people’s health through the development and commercialization of innovative products in the ophthalmology, osteoarthritis and aesthetic dermatology fields. Founded in 1976, the company is headquartered in Leobendorf, Austria (near Vienna) and employs approximately 400 individuals at its headquarters and subsidiaries in Austria, Germany, France, Poland, Romania Spain and the USA. Today as a global player Croma distributes its products in 62 countries via its own commercial sales organization(s), strategic partnerships and distributors.
For more information, visit www.croma.at
